Rani Therapeutics Hldgs (NASDAQ:RANI) is set to give its latest quarterly earnings report on Wednesday, 2024-03-20. Here's what investors need to know before the announcement.

Analysts estimate that Rani Therapeutics Hldgs will report an earnings per share (EPS) of $-0.32.

Rani Therapeutics Hldgs bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat EPS by $0.01, which was followed by a 3.03% drop in the share price the next day.

Here's a look at Rani Therapeutics Hldgs's past performance and the resulting price change:

Stock Performance

Shares of Rani Therapeutics Hldgs were trading at $3.34 as of March 18. Over the last 52-week period, shares are down 39.67%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Rani Therapeutics Hldgs visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.